EDITORIALS

Oxaliplatin for Colorectal Cancer in the United States: Better Late Than Never

Ian Chau and David Cunningham

JCO Jun 1 2003: 2049–2051. [Full Text] [PDF]

Molecular Oncodiagnostics: Where We Are and Where We Need to Go

Edison T. Liu

JCO Jun 1 2003: 2052–2055. [Full Text] [PDF]

Cyclin D1 Expression in the Field of Exposure: Another Piece in the Molecular Auerbach Puzzle

Jonathan M. Kurie

JCO Jun 1 2003: 2056–2058. [Full Text] [PDF]

ORIGINAL REPORTS
Gastrointestinal Cancer
	Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
	Mace L. Rothenberg, Amit M. Oza, Robert H. Bigelow, Jordan D. Berlin, John L. Marshall, Ramesh K. Ramanathan, Lowell L. Hart, Sunil Gupta, Carlos A. Garay, Brent G. Burger, Nathalie Le Bail, and Daniel G. Haller
	JCO Jun 1 2003: 2059–2069. [Abstract] [Full Text] [PDF]
	Asian Ethnicity–Related Differences in Gastric Cancer Presentation and Outcome Among Patients Treated at a Canadian Cancer Center
	Sharlene Gill, Amil Shah, Nhu Le, E. Francis Cook, and Eric M. Yoshida
	JCO Jun 1 2003: 2070–2076. [Abstract] [Full Text] [PDF]

Clinical Trials
	Quality Assessment of Genetic Markers Used for Therapy Stratification
	I.M. Ambros, J. Benard, M. Boavida, N. Bown, H. Caron, V. Combaret, J. Couturier, C. Darnfors, O. Delattre, J. Freeman-Edward, C. Gambini, N. Gross, C.M. Hattinger, A. Luegmayr, J. Lunec, T. Martinsson, K. Mazzocco, S. Navarro, R. Noguera, S. O’Neill, U. Pötschger, S. Rumpler, F. Speleman, G.P. Tonini, A. Valent, N. Van Roy, G. Amann, B. De Bernardi, P. Kogner, R. Ladenstein, J. Michon, A.D.J. Pearson, and P.F. Ambros
	JCO Jun 1 2003: 2077–2084. [Abstract] [Full Text] [PDF]

Lung Cancer
	Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival
	D. Ratschiller, J. Heighway, M. Gugger, A. Kappeler, F. Pirnia, R.A. Schmid, M.M. Borner, and D.C. Betticher
	JCO Jun 1 2003: 2085–2093. [Abstract] [Full Text] [PDF]
	Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer
	Vincent A. Miller, David H. Johnson, Lee M. Krug, Barbara Pizzo, Leslie Tyson, Wendy Perez, Peggy Krozely, Alan Sandler, David Carbone, Robert T. Heelan, Mark G. Kris, Robert Smith, and Judith Ochs
	JCO Jun 1 2003: 2094–2100. [Abstract] [Full Text] [PDF]

Breast Cancer
	Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group
	Henning Mouridsen, Mikhail Gershanovich, Yan Sun, Ramón Pérez-Carrión, Corrado Boni, Alain Monnier, Justus Apffelstaedt, Robert Smith, Harm P. Sleeboom, Fritz Jaenicke, Anna Pluzanska, Magdolna Dank, Dominique Becquart, Poonamalle P. Bapsy, Eeva Salminen, Ray Snyder, Hilary Chaudri-Ross, Raquel Lang, Peter Wyld, and Ajay Bhatnagar
	JCO Jun 1 2003: 2101–2109. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93
	Scott Wadler, Donna E. Levy, Sarah T. Lincoln, Gamini S. Soori, Julian C. Schink, and Gary Goldberg
	JCO Jun 1 2003: 2110–2114. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s Lymphoma
	John F. Seymour, Barbara Pro, Lillian M. Fuller, John T. Manning, Fredrick B. Hagemeister, Jorge Romaguera, Maria A. Rodriguez, Chul S. Ha, Terry L. Smith, Ana Ayala, Mark Hess, James D. Cox, Fernando Cabanillas, and Peter McLaughlin
	JCO Jun 1 2003: 2115–2122. [Abstract] [Full Text] [PDF]
	Therapy-Related Acute Promyelocytic Leukemia
	M. Beaumont, M. Sanz, P.M. Carli, F. Maloisel, X. Thomas, L. Detourmignies, A. Guerci, N. Gratecos, C. Rayon, J. San Miguel, J. Odriozola, J.Y. Cahn, F. Huguet, A. Vekhof, A. Stamatoulas, H. Dombret, F. Capote, J. Esteve, A.M. Stoppa, and P. Fenaux
	JCO Jun 1 2003: 2123–2137. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study
	Elizabeth A. Hahn, G. Alastair Glendenning, Mark V. Sorensen, Stacie A. Hudgens, Brian J. Druker, Francois Guilhot, Richard A. Larson, Stephen G. O’Brien, Deborah G. Dobrez, Martee L. Hensley, and David Cella
	JCO Jun 1 2003: 2138–2146. [Abstract] [Full Text] [PDF]
	Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy of Antiemetic Treatment in Cancer Patients
	Pierre-Benoit Tremblay, Rolf Kaiser, Orhan Sezer, Nadja Rösler, Claudia Schelenz, Kurt Possinger, Ivar Roots, and Jürgen Brockmöller
	JCO Jun 1 2003: 2147–2155. [Abstract] [Full Text] [PDF]
	Patient Preference for Radiotherapy Fractionation Schedule in the Palliation of Painful Bone Metastases
	Thomas P. Shakespeare, Jiade J. Lu, Michael F. Back, Shen Liang, Rahul K. Mukherjee, and Christopher J. Wynne
	JCO Jun 1 2003: 2156–2162. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era
	Anthony V. D’Amico, Judd Moul, Peter R. Carroll, Leon Sun, Deborah Lubeck, and Ming-Hui Chen
	JCO Jun 1 2003: 2163–2172. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Groups Potentially at Risk for Making Poorly Informed Decisions About Entry into Clinical Trials for Childhood Cancer
	Christian Simon, Stephen J. Zyzanski, Michelle Eder, Pauline Raiz, Eric D. Kodish, and Laura A. Siminoff
	JCO Jun 1 2003: 2173–2178. [Abstract] [Full Text] [PDF]
	Metastatic Melanoma in Pregnancy: Risk of Transplacental Metastases in the Infant
	April Alexander, Wolfram E. Samlowski, Douglas Grossman, Carol S. Bruggers, Ronald M. Harris, John J. Zone, R. Dirk Noyes, Glen M. Bowen, and Sancy A. Leachman
	JCO Jun 1 2003: 2179–2186. [Abstract] [Full Text] [PDF]
	High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Children and Adults With Newly Diagnosed Pineoblastomas
	Sridharan Gururangan, Colleen McLaughlin, Jennifer Quinn, Jeremy Rich, David Reardon, Edward C. Halperin, James Herndon, II, Herbert Fuchs, Timothy George, James Provenzale, Melody Watral, Roger E. McLendon, Allan Friedman, Henry S. Friedman, Joanne Kurtzberg, James Vredenbergh, and Paul L. Martin
	JCO Jun 1 2003: 2187–2191. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416
	B.C. Kuenen, M. Levi, J.C.M. Meijers, V.W.M. van Hinsbergh, J. Berkhof, A.K. Kakkar, K. Hoekman, and H.M. Pinedo
	JCO Jun 1 2003: 2192–2198. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Critical Review of Complementary Therapies for Prostate Cancer
	Simon Wilkinson and Gerald W. Chodak
	JCO Jun 1 2003: 2199–2210. [Abstract] [Full Text] [PDF]

ART OF ONCOLOGY

Why Not Start With Thalidomide?

Charles Loprinzi and S. Vincent Rajkumar

JCO Jun 1 2003: 2211–2214. [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case: Case 1. Clinical Complete Response of Breast Cancer Metastases After Trastuzumab-Based Immunotherapy

Giuseppe Tonini, Bruno Vincenzi, Daniele Santini, Giuseppe Avvisati, Annalisa La Cesa, and Alfonso Baldi

JCO Jun 1 2003: 2215–2216. [Full Text] [PDF]

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case: Case 2. Aggressive Fibromatosis of the Chest Wall Arising Near a Breast Prosthesis

Kaouthar Khanfir, Jean-Marc Guinebretière, Daniel Vanel, Lise Barreau-Pouhaer, Sylvie Bonvalot, and Axel Le Cesne

JCO Jun 1 2003: 2216–2218. [Full Text] [PDF]

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case: Case 3. Simultaneous and Synchronous Bilateral Inflammatory Breast Cancer

Bharat L. Agrawal, Amaresh R. Nath, Thomas P. Glynn, Jr, David Velazco, and Richard F. Garnett, Jr

JCO Jun 1 2003: 2218–2220. [Full Text] [PDF]

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case: Case 4. Primary Lymphoepithelioma-like Carcinoma of the Lung

Hanna Y. Irie, Michael T. Jaklitsch, Kitt Shaffer, Michael Weinstein, and Ravi Salgia

JCO Jun 1 2003: 2220–2222. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Guidelines for the Use of Epoetin: Have Quality-of-Life Benefits Been Proven?

Andrew Bottomley, Ronald Thomas, Kristel Van Steen, Henning Flechtner, and Alexander de Graeff

JCO Jun 1 2003: 2223. [Full Text] [PDF]

Whether an Increase in Hemoglobin Above 12 g/dL Is of Clinical Benefit

Thomas Ng

JCO Jun 1 2003: 2223-a–2224. [Full Text] [PDF]

Androgen Augmentation of Epoetin

Harry W. Daniell

JCO Jun 1 2003: 2224. [Full Text] [PDF]

In Reply:

J. Douglas Rizzo, David Cella, and Jerome Seidenfeld

JCO Jun 1 2003: 2224-a–2225. [Full Text] [PDF]

Errata

Erratum

JCO Jun 1 2003: 2226. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.